The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.
Pablo Artigas, Ph.D., from TTHSC's School of Medicine’s Department of Cell Physiology and Molecular Biophysics, published a study with his team of collaborators in Nature Communications.
Samuel Prien, Ph.D., and Lindsay Penrose, Ph.D., from the Department of Obstetrics and Gynecology have recently yielded a patent to help address these male-related issues and raise the rate of successful pregnancies.
Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.
In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.
With a regional I-Corps Innovation Hub just down the street from TTUHSC's Lubbock campus, there are continuous opportunities for participation from students and faculty within the Texas Tech University System.
Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.
Primarily found in sub-Saharan Africa, the Middle East, Southeast Asia and the Caribbean, schistosomiasis is second only to malaria as a deadly tropical parasitic disease.
Cancer experts are ringing alarm bells due to the rise in uterine cancer. Numbers of uterine cancer annually are now equal to ovarian cancer.
A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.
Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.
TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution
The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.
CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.
Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.
Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.
To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.
The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.
In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).
To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.
The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.
- #Breast Center of Excellence
- #Campus Life
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Feature Stories
- #Garrison Institute on Aging
- #Graduate School of Biomedical Sciences
- #Laura W. Bush Institute for Women's Health
- #Mental Health Initiative
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #Public Art
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #Team Member Spotlight
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Women's Health